{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/33862"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/33862","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"Synthesis of Metergoline Analogues With Pendant Amines gor Increased Gram-Negative Permeability","abstract":"Gram-negative bacterial infections are becoming challenging to treat as antimicrobial resistance grows increasingly common, and the Gram-negative outer membrane poses a significant barrier to entry for antibiotics. New scaffolds with novel mechanisms of action are of key importance to addressing antibiotic resistance and avoiding cross-resistance with existing antibiotic classes. This thesis discusses the identification of the ergot alkaloid metergoline as one such potential scaffold and ongoing efforts to convert metergoline into a broad-spectrum antibiotic. Chapter 1 focuses on the unique challenges associated with developing novel therapies for Gram-negative infections and the development of the eNTRy rules as a means of improving accumulation within Gram-negative pathogens. A brief history of metergoline’s discovery and development as an antibiotic is also discussed. Chapter 2 focuses on ongoing efforts to convert metergoline from a Gram-positive only antibiotic to a broad-spectrum agent via application of the eNTRy rules. Synthetic routes to introduce primary amine side chains to metergoline are described herein. The resulting analogues were tested for activity against WT E. coli, and the most promising side chain was combined with activity-enhancing modifications discovered during a previous SAR study. The outcome of this work was a metergoline analogue with potent activity against WT E. coli that is a promising lead for future development of a novel broad-spectrum antibiotic.","abstract_html":"Gram-negative bacterial infections are becoming challenging to treat as antimicrobial resistance grows increasingly common, and the Gram-negative outer membrane poses a significant barrier to entry for antibiotics. New scaffolds with novel mechanisms of action are of key importance to addressing antibiotic resistance and avoiding cross-resistance with existing antibiotic classes. This thesis discusses the identification of the ergot alkaloid metergoline as one such potential scaffold and ongoing efforts to convert metergoline into a broad-spectrum antibiotic. Chapter 1 focuses on the unique challenges associated with developing novel therapies for Gram-negative infections and the development of the eNTRy rules as a means of improving accumulation within Gram-negative pathogens. A brief history of metergoline’s discovery and development as an antibiotic is also discussed. Chapter 2 focuses on ongoing efforts to convert metergoline from a Gram-positive only antibiotic to a broad-spectrum agent via application of the eNTRy rules. Synthetic routes to introduce primary amine side chains to metergoline are described herein. The resulting analogues were tested for activity against WT E. coli, and the most promising side chain was combined with activity-enhancing modifications discovered during a previous SAR study. The outcome of this work was a metergoline analogue with potent activity against WT E. coli that is a promising lead for future development of a novel broad-spectrum antibiotic.","abstract_has_math":false,"creators":["Shepherd, Emma Katherine"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Chemical Biology","school":null,"contributors":[],"advisors":["Magolan, Jakob"],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T19:38:30Z","subjects":["Antibiotics","E. Coli","Ergot alkaloids"],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/25632"],"render_values":[{"text":"https://doi.org/10.71548/25632","href":"https://doi.org/10.71548/25632","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/11375/33862","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/11375/33862","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F33862","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Magolan, Jakob"]},{"key":"dc:contributor.department","label":"Department","values":["Chemical Biology"]},{"key":"dc:creator","label":"Author","values":["Shepherd, Emma Katherine"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-10-15T19:07:06Z"]},{"key":"dc:date.issued","label":"Date","values":["2026"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Antibiotics","E. Coli","Ergot alkaloids"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/11375/33862","https://doi.org/10.71548/25632"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Gram-negative bacterial infections are becoming challenging to treat as antimicrobial resistance grows increasingly common, and the Gram-negative outer membrane poses a significant barrier to entry for antibiotics. New scaffolds with novel mechanisms of action are of key importance to addressing antibiotic resistance and avoiding cross-resistance with existing antibiotic classes. This thesis discusses the identification of the ergot alkaloid metergoline as one such potential scaffold and ongoing efforts to convert metergoline into a broad-spectrum antibiotic. Chapter 1 focuses on the unique challenges associated with developing novel therapies for Gram-negative infections and the development of the eNTRy rules as a means of improving accumulation within Gram-negative pathogens. A brief history of metergoline’s discovery and development as an antibiotic is also discussed. Chapter 2 focuses on ongoing efforts to convert metergoline from a Gram-positive only antibiotic to a broad-spectrum agent via application of the eNTRy rules. Synthetic routes to introduce primary amine side chains to metergoline are described herein. The resulting analogues were tested for activity against WT E. coli, and the most promising side chain was combined with activity-enhancing modifications discovered during a previous SAR study. The outcome of this work was a metergoline analogue with potent activity against WT E. coli that is a promising lead for future development of a novel broad-spectrum antibiotic."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Master of Science (MSc)"]},{"key":"dc:title","label":"Title","values":["Synthesis of Metergoline Analogues With Pendant Amines gor Increased Gram-Negative Permeability"]},{"key":"others:access_status","label":"Others Access Status","values":["embargo"]}]}],"canonical_facts":{"dc:contributor.advisor":["Magolan, Jakob"],"dc:contributor.department":["Chemical Biology"],"dc:creator":["Shepherd, Emma Katherine"],"dc:date.accessioned":["2026-10-15T19:07:06Z"],"dc:date.issued":["2026"],"dc:description.abstract":["Gram-negative bacterial infections are becoming challenging to treat as antimicrobial resistance grows increasingly common, and the Gram-negative outer membrane poses a significant barrier to entry for antibiotics. New scaffolds with novel mechanisms of action are of key importance to addressing antibiotic resistance and avoiding cross-resistance with existing antibiotic classes. This thesis discusses the identification of the ergot alkaloid metergoline as one such potential scaffold and ongoing efforts to convert metergoline into a broad-spectrum antibiotic. Chapter 1 focuses on the unique challenges associated with developing novel therapies for Gram-negative infections and the development of the eNTRy rules as a means of improving accumulation within Gram-negative pathogens. A brief history of metergoline’s discovery and development as an antibiotic is also discussed. Chapter 2 focuses on ongoing efforts to convert metergoline from a Gram-positive only antibiotic to a broad-spectrum agent via application of the eNTRy rules. Synthetic routes to introduce primary amine side chains to metergoline are described herein. The resulting analogues were tested for activity against WT E. coli, and the most promising side chain was combined with activity-enhancing modifications discovered during a previous SAR study. The outcome of this work was a metergoline analogue with potent activity against WT E. coli that is a promising lead for future development of a novel broad-spectrum antibiotic."],"dc:description.degree":["Master of Science (MSc)"],"dc:identifier.uri":["https://hdl.handle.net/11375/33862","https://doi.org/10.71548/25632"],"dc:language.iso":["en"],"dc:subject":["Antibiotics","E. Coli","Ergot alkaloids"],"dc:title":["Synthesis of Metergoline Analogues With Pendant Amines gor Increased Gram-Negative Permeability"],"dc:type":["Thesis"],"others:access_status":["embargo"]},"updated_at":"2026-11-18T19:38:30Z"}